Frequently Asked Questions

Rexon-Eye is generally well tolerated and non-invasive. Your clinician will discuss any potential risks and suitability during your consultation.

Yes. Many patients benefit from combination therapy when multiple factors contribute to their dry eye disease.

Dry eye disease is typically a chronic condition. Rexon-Eye aims to improve ocular surface health and reduce symptoms, but ongoing management may still be required.

Most treatment protocols involve four sessions. Some patients may require additional treatment depending on the severity of their condition.

Some patients notice improvement within weeks of treatment, while others experience more gradual changes over several months.

No. Most patients find the treatment comfortable and relaxing.

Potentially. Following a comprehensive assessment, we can determine whether Rexon-Eye may be beneficial as part of a personalised treatment plan.